Send Enquiry

MEDANOR
Injection
Packaging and packing Type
| 1
MRP :
₹261.56
PTR :
₹199.28
PTS :
₹179.36
Hospital use Read More
Composition
Send Enquiry
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
From Vibcare Pharma's Medanor division, Norafos Injection is an intravenous injection with Iron Sucrose 20mg as its active ingredient. It is grouped with haematinic and anti-anaemic medicines, and the pack is 5ml.
The injection provides iron in the form of an iron-sucrose complex. Once given into a vein, it dissociates into iron and sucrose, and the iron is transported as a complex with transferrin to cells including erythroid precursor cells. It is then incorporated into haemoglobin as those cells grow into red blood cells.
It is used for the treatment of iron deficiency anaemia in patients with chronic kidney disease. Blood pressure must be monitored during and following each administration, and the patient must be observed for signs of hypersensitivity during and for at least 30 minutes after each administration. It should be given only when personnel and treatment for serious hypersensitivity reactions are immediately available.
Given only by a doctor or nurse.
Common
Get medical help at once if you notice
Do not use
Ask a doctor first
Norafos Injection supplies iron sucrose 20mg intravenously for the treatment of iron deficiency anaemia in chronic kidney disease. Main uses: treatment of iron deficiency anaemia in patients with chronic kidney disease; iron replacement in patients who have iron deficiency anaemia because of chronic kidney disease; helps supply iron that is incorporated into haemoglobin as red blood cells mature.
Common side effects of Norafos Injection include diarrhoea; nausea; vomiting; headache; dizziness; low blood pressure (hypotension). Get medical help at once if you notice serious hypersensitivity reactions, including anaphylactic-type reactions, some of which have been life-threatening or fatal; low blood pressure (hypotension) during or after administration; blood pressure must be monitored during and following each administration; iron overload if too much iron builds up in the body; blood counts must be checked regularly during therapy.
Norafos Injection contains Iron Sucrose 20 mg. Norafos Injection is given by a doctor or nurse, who decides the dose and how often it is given.
The MRP of Norafos Injection is ₹261.56 for a pack of 1. For chemists and distributors, the PTR is ₹199.28 and the PTS is ₹179.36.
Norafos Injection contains Iron Sucrose 20 mg. It comes in a pack of 1.
The injection provides iron in the form of an iron-sucrose complex. Once given into a vein, it dissociates into iron and sucrose, and the iron is transported as a complex with transferrin to cells including erythroid precursor cells. It is then incorporated into haemoglobin as those cells grow into red blood cells.
Must not be used by patients with known hypersensitivity to iron sucrose. Must not be used in patients with iron overload. Check with a doctor first if you have a history of allergic reactions to any iron injection. Check with a doctor first if you have low blood pressure, asthma or allergy to medicines.
Norafos Injection is a brand of Vibcare Pharma, sold through its Medanor division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Similar Products
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner